Mineralys Therapeutics
The Senior Director, Analytical Sciences provides strategic and technical leadership for analytical activities supporting the development, registration, and lifecycle management of small molecule drug substances and products. This role involves establishing analytical strategies, managing method lifecycle and specifications, and overseeing external partners and regulatory submissions. The position requires cross-functional collaboration to ensure alignment with quality, regulatory, and business objectives throughout the drug development and commercialization process.
Headquarters
Radnor, Pennsylvania, United States
Company Size
11-50 employees
Founded
2020
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on improving outcomes for people with hypertension, chronic kidney disease (CKD), and cardio-renal-metabolic diseases driven by dysregulated aldosterone. The company's lead investigational candidate, Lorundrostat, is designed to target the underlying role of aldosterone in these conditions. Mineralys is advancing its pipeline through clinical development with the goal of delivering better outcomes for patients inadequately served by current therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Mineralys Therapeutics.
Decoding Mineralys Therapeutics Inc (MLYS): A Strategic SWOT Insight
3 days ago
Executive Director, Analytical Development (Small Molecule)
Structure Therapeutics
Analytical Chemist
Vanda Pharmaceuticals
Analytical Chemist
Vanda Pharmaceuticals
Senior Manager, Analytical Chemistry
Enliven
Principal Scientist, Analytical Development
Praxis Precision Medicines, Inc.
Principal Scientist, Pharmaceutical Analytical Sciences
Merck & Co., Inc.